ATAC Case Study - Andy Chapman, GSK @cellandgenetherapycatapult
ATAC Case Study - Andy Chapman, GSK @cellandgenetherapycatapult
Uploaded June 2021 | Updated September 2026, 2 weeks ago
ATAC Case Study - Andy Chapman, GSKEmployee Spotlight: Shereece Szelwicki, Senior Tech Transfer SpecialistCell and Gene Therapy Catapults Braintree Manufacturing Innovation CentreATTC network event 2024: Interview with Kath Bainbridge, Department of Health and Social CareCell and Gene Therapy Catapults London Office and LaboratoriesWhat is ATAC and how does it support the advanced therapies industry?ATTC network event 2025: Interview with Jacqueline Barry, Cell and Gene Therapy CatapultFireside Chat: Challenges and perspectives on gene therapyATTC network event 2025: Interview with Fiona Thistlethwaite, iMATCH ATTCImpact of the Advanced Therapies Apprenticeship CommunityIntroducing the Cell and Gene Therapy Catapult Edinburgh office and laboratoriesMeet Rolando Matos, Senior Bioprocessing Scientist | In and out of the lab
Cell and Gene Therapy Catapult |

ATAC Case Study - Andy Chapman, GSK

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER